50 employees
RegStem is an early stage biopharmaceutical company repurposing molecules.
2017
$81K
from 1 investors over 1 rounds
RegStem raised $81K on November 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)